These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38920258)

  • 1. Post-Acute Sequelae of COVID-19 Checklist (PASC-C): a screening tool for Long COVID physical, psychological, and cognitive symptoms.
    Mancini D; Maffoni M; Torlaschi V; Gorini A; La Rovere MT; Fundarò C; Fanfulla F; Bussotti M; Masnaghetti S; Pierobon A
    Ann Ist Super Sanita; 2024; 60(1):47-54. PubMed ID: 38920258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pulmonary rehabilitation on functional and psychological parameters in post-acute sequelae of SARS-CoV-2 infection (PASC) patients.
    Nasrullah A; Virk S; Javed A; Shah A; Ramanujam D; Sharma A; Gutierrez L; Nauer K; Maggio M; Yin Y; Bajwa Y; Cheema T; Disilvio B
    BMC Pulm Med; 2024 May; 24(1):231. PubMed ID: 38745298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.
    LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP
    BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological post-acute sequelae of SARS-CoV-2 infection.
    Takao M; Ohira M
    Psychiatry Clin Neurosci; 2023 Feb; 77(2):72-83. PubMed ID: 36148558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Disease Self-Management of Post-Acute Sequelae of COVID-19 Among Older Adults: A Mixed-Methods Analysis.
    Thomas-Purcell K; Davenport R; Ayala V; Purcell D; Ownby RL
    Clin Interv Aging; 2023; 18():607-617. PubMed ID: 37082741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-acute sequelae of SARS-CoV-2 associates with physical inactivity in a cohort of COVID-19 survivors.
    Gil S; Gualano B; de Araújo AL; de Oliveira Júnior GN; Damiano RF; Pinna F; Imamura M; Rocha V; Kallas E; Batistella LR; Forlenza OV; de Carvalho CRR; Busatto GF; Roschel H;
    Sci Rep; 2023 Jan; 13(1):215. PubMed ID: 36604523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised controlled trial testing the efficacy of Fit after COVID, a cognitive behavioural therapy targeting severe post-infectious fatigue following COVID-19 (ReCOVer): study protocol.
    Kuut TA; Müller F; Aldenkamp A; Assmann-Schuilwerve E; Braamse A; Geerlings SE; Gibney KB; Kanaan RAA; Nieuwkerk P; Olde Hartman TC; Pauëlsen D; Prins M; Slieker K; Van Vugt M; Bleeker-Rovers CP; Keijmel SP; Knoop H
    Trials; 2021 Dec; 22(1):867. PubMed ID: 34857010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin.
    Pretorius E; Vlok M; Venter C; Bezuidenhout JA; Laubscher GJ; Steenkamp J; Kell DB
    Cardiovasc Diabetol; 2021 Aug; 20(1):172. PubMed ID: 34425843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal analysis and treatment of neuropsychiatric symptoms in post-acute sequelae of COVID-19.
    Liu EN; Yang JH; Patel L; Arora J; Gooding A; Ellis R; Graves JS
    J Neurol; 2023 Oct; 270(10):4661-4672. PubMed ID: 37493802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period.
    Dagher H; Chaftari AM; Subbiah IM; Malek AE; Jiang Y; Lamie P; Granwehr B; John T; Yepez E; Borjan J; Reyes-Gibby C; Flores M; Khawaja F; Pande M; Ali N; Rojo R; Karp DD; Chaftari P; Hachem R; Raad II
    Elife; 2023 Feb; 12():. PubMed ID: 36748905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive brain stimulation for fatigue in post-acute sequelae of SARS-CoV-2 (PASC).
    Santana K; França E; Sato J; Silva A; Queiroz M; de Farias J; Rodrigues D; Souza I; Ribeiro V; Caparelli-Dáquer E; Teixeira AL; Charvet L; Datta A; Bikson M; Andrade S
    Brain Stimul; 2023; 16(1):100-107. PubMed ID: 36693536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-acute sequelae of SARS-CoV-2 infection: relationship of central nervous system manifestations with physical disability and systemic inflammation.
    Busatto GF; de Araujo AL; Castaldelli-Maia JM; Damiano RF; Imamura M; Guedes BF; de Rezende Pinna F; Sawamura MVY; Mancini MC; da Silva KR; Garcia ML; Sumita N; Brunoni AR; da Silva Duarte AJ; Burdmann EA; Kallas EG; Cerri GG; Nitrini R; Bento RF; Rocha VG; de Souza HP; Miguel EC; de Carvalho CRR; Forlenza OV; Batistella LR;
    Psychol Med; 2022 Sep; 52(12):2387-2398. PubMed ID: 35521752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.
    Moghimi N; Di Napoli M; Biller J; Siegler JE; Shekhar R; McCullough LD; Harkins MS; Hong E; Alaouieh DA; Mansueto G; Divani AA
    Curr Neurol Neurosci Rep; 2021 Jun; 21(9):44. PubMed ID: 34181102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased SARS-CoV-2 reactive low avidity T cells producing inflammatory cytokines in pediatric post-acute COVID-19 sequelae (PASC).
    Paniskaki K; Goretzki S; Anft M; Konik MJ; Meister TL; Pfaender S; Lechtenberg K; Vogl M; Dogan B; Dolff S; Westhoff TH; Rohn H; Felderhoff-Mueser U; Stervbo U; Witzke O; Dohna-Schwake C; Babel N
    Pediatr Allergy Immunol; 2023 Dec; 34(12):e14060. PubMed ID: 38146118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC).
    Pretorius E; Venter C; Laubscher GJ; Kotze MJ; Oladejo SO; Watson LR; Rajaratnam K; Watson BW; Kell DB
    Cardiovasc Diabetol; 2022 Aug; 21(1):148. PubMed ID: 35933347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What's going on following acute covid-19? Clinical characteristics of patients in an out-patient rehabilitation program.
    Albu S; Zozaya NR; Murillo N; García-Molina A; Chacón CAF; Kumru H
    NeuroRehabilitation; 2021; 48(4):469-480. PubMed ID: 33998551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and determinants of post-acute sequelae of COVID-19 in Liberia.
    Gwaikolo C; Sackie-Wapoe Y; Badio M; Glidden DV; Lindan C; Martin J
    Int J Epidemiol; 2024 Feb; 53(1):. PubMed ID: 38052015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The other COVID-19 survivors: Timing, duration, and health impact of post-acute sequelae of SARS-CoV-2 infection.
    Lambert N; ; El-Azab SA; Ramrakhiani NS; Barisano A; Yu L; Taylor K; Esperança Á; Mendiola C; Downs CA; Abrahim HL; Hughes T; Rahmani AM; Borelli JL; Chakraborty R; Pinto MD
    J Clin Nurs; 2024 Jan; 33(1):76-88. PubMed ID: 36181315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors associated with post-acute sequelae of SARS-CoV-2: an N3C and NIH RECOVER study.
    Hill EL; Mehta HB; Sharma S; Mane K; Singh SK; Xie C; Cathey E; Loomba J; Russell S; Spratt H; DeWitt PE; Ammar N; Madlock-Brown C; Brown D; McMurry JA; Chute CG; Haendel MA; Moffitt R; Pfaff ER; Bennett TD; ;
    BMC Public Health; 2023 Oct; 23(1):2103. PubMed ID: 37880596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-Related Quality of Life for Patients with Post-Acute COVID-19 Syndrome: Identification of Symptom Clusters and Predictors of Long-Term Outcomes.
    Lapin B; Li Y; Englund K; Katzan IL
    J Gen Intern Med; 2024 Jun; 39(8):1301-1309. PubMed ID: 38424349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.